We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Congenital Cytomegalovirus Infection Predicted in High-Risk Pregnant Women

By LabMedica International staff writers
Posted on 08 Dec 2016
Print article
Image: Transmission electron microscopic (TEM) depicts numbers of cytomegalovirus (CMV) virions that were present in a tissue sample (Photo courtesy of Sylvia Whitfield).
Image: Transmission electron microscopic (TEM) depicts numbers of cytomegalovirus (CMV) virions that were present in a tissue sample (Photo courtesy of Sylvia Whitfield).
Congenital cytomegalovirus (CMV) infection can cause serious complications such as hearing difficulties and mental delay in affected infants. A new method for predicting congenital CMV infection during the prenatal period has been discovered. This method is safe for both mothers and fetuses, and could potentially be adopted for general use.

In the USA over 8,000 children a year suffer from the long-term complications of congenital CMV infection and the annual costs of caring for these children are estimated at USD 1-2 billions. To facilitate this, early diagnosis is vital; however, tests to identify the infection in infants, such as molecular tests that detect virus DNA in infants' urine, are not widely carried out, and would incur huge financial costs if they were carried out for all infants.

Scientists affiliated with the Kobe University Graduate School of Medicine (Kobe, Japan) surveyed 300 pregnant women who tested positive for CMV immunoglobulin M (IgM) antibodies and were classified as high-risk for congenital infection. The team carried out clinical interviews, blood tests, ultrasounds, and DNA polymerase chain reaction (PCR) tests for CMV using samples of the subjects' blood, urine and uterine cervical secretion. The maternal clinical and laboratory findings, including serum CMV IgM and IgG, IgG avidity index (AI), direct immunoperoxidase staining of leukocytes with peroxidase-labeled monoclonal antibody (C7-HRP test) testing, and PCR for the detection of CMV-DNA in the maternal serum, urine, and uterine cervical secretion, and prenatal ultrasound findings were evaluated.

The team reported that in 22 of the 300 women, congenital infection was confirmed using PCR for CMV-DNA in newborn urine. Univariate analyses demonstrated that the presence of maternal flu-like symptoms, presence of ultrasound fetal abnormalities, serum titers of CMV IgM, positive results for C7-HRP, CMV IgG AI less than 40%, and positive PCR results in the uterine cervical secretion were statistically associated with the occurrence of congenital CMV infection. Multivariable analysis revealed that the presence of ultrasound fetal abnormalities and positive PCR results in the uterine cervical secretion were independent predictive factors of congenital CMV infection in CMV IgM-positive women.

The authors concluded that both ultrasound and PCR tests for uterine cervical secretion are non-invasive procedures, and using them can offer a safer method to test high-risk pregnant women and predict the occurrence of congenital infection. Accurately identifying the affected infants enables doctors to start antiviral treatment early, and could improve the neurological prognosis of infants infected by CMV. The study was published online on October, 20, 2016, in the journal Clinical Infectious Diseases.

Related Links:
Kobe University Graduate School of Medicine

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
HIV-1 Test
HIV-1 Real Time RT-PCR Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.